RxDoctor Payments Data

Jason Hensler, PA

Medical · McAllen, TXNPI 1356345763

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Optinose US, Inc. accounts for 73.1% of it on its own, with 23 other manufacturers making up the rest. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$65,980in general payments, 2019–2025

Across 443 payments — averaging $148.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$48K
  • Medtronic$6K
  • Sanofi$4K
  • Regeneron Healthcare Solutions, Inc.$1K
  • AstraZeneca$1K
  • Aerin Medical Inc.$818
  • plus $4K from 18 others

What the payments were for

  • Consulting fees$2,9765%
  • Speaking & faculty fees$34,87053%
  • Travel & lodging$12,49619%
  • Food & beverage$15,57124%
  • Education$660%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$65,980 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas

Medicare billing

Part B allowed, 2024
$56,701
Medicare patients
235
Services billed
1,036

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth61$6,990
Ipratropium Bromide127$3,712
Fluticasone Propionate169$2,457
Cefdinir76$1,469
Mometasone Furoate60$1,303
Prednisolone33$990
Pilocarpine Hcl21$890
Prednisolone Sodium Phosphate118$875
Pantoprazole Sodium96$457
Famotidine32$359
Clotrimazole11$345
Carbinoxamine Maleate12$243
Ofloxacin11$158
Montelukast Sodium14$154
Azithromycin25$139

Paid to pharmacies, not to this prescriber.

Other medical in McAllen

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →